Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
Q2 2025 vs. Q1 2025
How the institutions holding Kiora Pharmaceuticals Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 18 | 16 | −2 |
| Shares | 1.29M | 931.8K | −353.6K (−27.5%) |
| Value | $3.87M | $2.68M | −$1.19M (−30.6%) |
New holders (2)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 35 | $101 | 0.00% |
| Raymond James Financial Inc | 2 | $6 | 0.00% |
Sold out (4)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Rosalind Advisors, Inc. | 250,059 | $752.7K |
| Citadel Advisors LLC | 26,550 | $79.9K |
| Sabby Management, LLC | 5,000 | $15.1K |
| Morgan Stanley | 700 | $2.11K |